116 related articles for article (PubMed ID: 28718702)
1. A novel t(3;9)(q21.2; p24.3) associated with SMARCA2 and ZNF148 genes rearrangement in myelodysplastic syndrome.
Coccaro N; Brunetti C; Tota G; Pierri CL; Anelli L; Zagaria A; Casieri P; Impera L; Minervini CF; Minervini A; Cumbo C; Ricco A; Carluccio P; Orsini P; Specchia G; Albano F
Leuk Lymphoma; 2018 Apr; 59(4):996-999. PubMed ID: 28718702
[No Abstract] [Full Text] [Related]
2. An atypical myelodysplastic syndrome with t(9;12)(q22;p12) and TEL gene rearrangement.
Kuno Y; Abe A; Emi N; Iida M; Yamamori T; Tanimoto M; Saito H
Br J Haematol; 1999 Aug; 106(2):570-1. PubMed ID: 10460625
[No Abstract] [Full Text] [Related]
3. MEL1S, not MEL1, is overexpressed in myelodysplastic syndromes patients with t(1;3)(p36;q21).
Xiao Z; Zhang M; Liu X; Zhang Y; Yang L; Hao Y
Leuk Res; 2006 Mar; 30(3):332-4. PubMed ID: 16102824
[TBL] [Abstract][Full Text] [Related]
4. A case of atypical myelodysplastic syndrome with a novel reciprocal translocation t(1;12)(q21;p13).
Sánchez J; Serrano J; Román J; García JM; Nomdedéu J; Torres A
Haematologica; 2000 Apr; 85(4):434-5. PubMed ID: 10756375
[No Abstract] [Full Text] [Related]
5. A case of atypical myelodysplastic syndrome with micromegakaryocytes, normal platelet count, and t(3;12)(q21;p13) with inv(3)(q21q26).
Schnittger S; Schoch C; Streubel B; Hinrichs HF; Otremba B; Parwaresch R; Fonatsch C
Genes Chromosomes Cancer; 1997 Nov; 20(3):292-8. PubMed ID: 9365837
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal translocation t(9;22)(p24;q11) appears to be recurrently associated with myeloid malignancy with aggressive course.
Angelova S; Spassova S; Toshkov S; Shivarov V
Leuk Lymphoma; 2011 Sep; 52(9):1809-10. PubMed ID: 21663511
[No Abstract] [Full Text] [Related]
7. A novel t(1;12)(q21;q24) in a patient with myelodysplastic syndrome.
Park TS; Lee SG; Song J; Kim JS; Choi JR
Ann Hematol; 2010 May; 89(5):513-6. PubMed ID: 19697027
[No Abstract] [Full Text] [Related]
8. Translocation t(3;4)(q26;q21) in myelodysplastic syndrome with megakaryoblastic proliferation.
Ohyashiki K; Enomoto Y; Watanabe Y; Nehashi Y; Ohyashiki JH; Toyama K
Cancer Genet Cytogenet; 1988 Aug; 34(1):5-9. PubMed ID: 3395994
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and laboratory study of 4 cases of myelodysplastic syndromes with t (1;3) (p36; q21)].
Zhang MR; Liu XP; Zhang Y; Yang L; Zhou XH; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):99-102. PubMed ID: 16732963
[TBL] [Abstract][Full Text] [Related]
10. Pseudoreticulocytosis in a case of myelodysplastic syndrome with translocation t(1;14) (q42;q32).
de Pree C; Cabrol C; Frossard JL; Beris P
Semin Hematol; 1995 Jul; 32(3):232-6. PubMed ID: 7570066
[No Abstract] [Full Text] [Related]
11. Diagnostic and prognostic significance of t(1;3)(p36;q21) in the disorders of hematopoiesis.
Welborn JL; Lewis JP; Jenks H; Walling P
Cancer Genet Cytogenet; 1987 Oct; 28(2):277-85. PubMed ID: 3476187
[TBL] [Abstract][Full Text] [Related]
12. A complex chromosome 3 rearrangement not affecting RPN1, EVI1/MDS1 genes in a patient with an atypical refractory cytopenia with multilineage dysplasia.
Bernasconi P; Dambruoso I; Cavigliano PM; Boni M; Travaglino E; Benatti C; Invernizzi R
Ann Hematol; 2008 Feb; 87(2):147-50. PubMed ID: 17960379
[No Abstract] [Full Text] [Related]
13. A discriminating screening is necessary to ascertain EVI1 expression by RT-PCR in malignant cells from the myeloid lineage without 3q26 rearrangement.
Zoccola D; Legros L; Cassuto P; Fuzibet JG; Nucifora G; Raynaud SD
Leukemia; 2003 Mar; 17(3):643-5. PubMed ID: 12646959
[No Abstract] [Full Text] [Related]
14. Reciprocal translocation involving 3q21 in an unusual myeloproliferative disorder with myelodysplastic features and prominent dysmegakaryopoiesis.
Cedrone M; Mecucci C; Burgio VL; Diverio D; Petti MC; Alimena G
Cancer Genet Cytogenet; 1991 Jan; 51(1):73-8. PubMed ID: 1984850
[TBL] [Abstract][Full Text] [Related]
15. Translocation (10;21)(q21;q22) in myelodysplastic syndrome.
Rashaan Z; Ito Y; Takaku T; Toyotake J; Miyazawa K; Kodama A; Ohyashiki K
Cancer Genet Cytogenet; 2007 Feb; 173(1):81-2. PubMed ID: 17284376
[No Abstract] [Full Text] [Related]
16. [Clinical and laboratory investigation of hematological malignancy patients carrying 3q21q26 rearrangement].
Xu FY; Liu XP; Qin S; Li CW; Lin D; Mi YC; Liu SH; Wang JX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):696-8. PubMed ID: 18067087
[TBL] [Abstract][Full Text] [Related]
17. Paroxysmal nocturnal hemoglobinuria-myelodysplastic syndrome associated with marked thrombocytosis and acquired clonal cytogenetic abnormality of t(3;12)(q28;q15).
Won EJ; Kim HR; Lee SY; Choi HJ; Won SJ; Shin JH; Suh SP; Ryang DW; Shin MG
Leuk Lymphoma; 2012 Jul; 53(7):1429-32. PubMed ID: 22192057
[No Abstract] [Full Text] [Related]
18. Breakpoint analysis by fluorescence in situ hybridization in myelodysplastic syndromes with t(3;12)(q26;p13) and expression of EVI1.
van de Loosdrecht AA; Kok K; de Vries B; van der Veen AY; van den Berg E; Esselink MT; Marynen P; Vellenga E; van Imhoff GW
Leukemia; 2000 Oct; 14(10):1857-8. PubMed ID: 11021761
[No Abstract] [Full Text] [Related]
19. [A case of atypical myelodysplastic syndrome with eosinophilia and complex cytogenetic changes t(3; 12)(q21; p13); t(16; 17); (q24; q12)].
Abdulkadyrov KM; Gritsaev SV; Rukavitsyn OA; Martynkevich IS; Tiranova SA; Balashova VA; Blinov MN; Kharchenko MF
Ter Arkh; 2002; 74(7):70-2. PubMed ID: 12181842
[No Abstract] [Full Text] [Related]
20. Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells.
Lahortiga I; Agirre X; Belloni E; Vázquez I; Larrayoz MJ; Gasparini P; Lo Coco F; Pelicci PG; Calasanz MJ; Odero MD
Oncogene; 2004 Jan; 23(1):311-6. PubMed ID: 14712237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
